Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modification of Epilepsy Screen Questionnaire and Treatment Feasibility Evaluation
NCT04939675Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Jul 2021
- Primary completion
- Jun 2023
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of zonisamide, levetiracetam and lamotrigine in epilepsy, sponsored by National Taiwan University Hospital. Primary endpoint: Mini-Mental State Examination at 12 weeks. Status: unknown.
02
Drugs
zonisamidelevetiracetamlamotrigine
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT04939675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04939675.